Financial Network Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Sell
4,942
-186
-4% -$7.99K 0.24% 85
2026
Q1
$188K Buy
5,128
+2,122
+71% +$101K 0.19% 95
2025
Q4
$153K Buy
3,006
+29
+1% +$1.48K 0.16% 117
2025
Q3
$165K Buy
2,977
+131
+5% +$7.67K 0.18% 106
2025
Q2
$196K Sell
2,846
-66
-2% -$4.49K 0.24% 81
2025
Q1
$202K Buy
2,912
+1,298
+80% +$107K 0.27% 72
2024
Q4
$139K Sell
1,614
-1,733
-52% -$187K 0.26% 78
2024
Q3
$399K Buy
3,347
+41
+1% +$5.47K 0.33% 63
2024
Q2
$472K Buy
3,306
+197
+6% +$26.1K 0.35% 66
2024
Q1
$399K Sell
3,109
-113
-4% -$13.5K 0.4% 65
2023
Q4
$333K Buy
+3,222
New +$319K 0.35% 74

Other funds holding NVO

Financial Network Wealth Advisors's NVO Position: Q2 2026 in Review

Financial Network Wealth Advisors reduced its Novo Nordisk (NVO) stake by 3.6% in Q2 2026, selling an estimated $7.99K and leaving 4,942 shares worth $237K. The position accounts for 0.24% of the portfolio, ranked #85.

Financial Network Wealth Advisors first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $472K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Financial Network Wealth Advisors held 4,942 shares of Novo Nordisk worth $237K as of Q2 2026.
  • Financial Network Wealth Advisors sold 186 Novo Nordisk shares in Q2 2026, an estimated $7.99K.
  • Novo Nordisk made up 0.24% of Financial Network Wealth Advisors's portfolio in Q2 2026, its #85 holding.
  • Financial Network Wealth Advisors first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Financial Network Wealth Advisors's Novo Nordisk position peaked at $472K in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.